Pharmaceutical Development Group

Executive Summary

Pharmaceutical Development Group (PDG) is a private consulting firm based in Boston, Massachusetts, founded in 2005. The company provides strategic consulting services for U.S. FDA submissions, product launches, and post-approval lifecycle management. PDG's expertise spans multiple dosage forms and therapeutic areas, positioning it as a versatile partner for pharmaceutical companies seeking regulatory guidance. While the firm has a stable business model serving a niche market, its lack of proprietary products or disclosed financials limits its growth visibility. As a service provider, PDG's performance is tied to industry demand for regulatory support, which remains robust given ongoing drug development trends. The company is estimated to have moderate but steady revenue, with no disclosed funding rounds or valuation.

Upcoming Catalysts (preview)

• Q2 2026Announcement of partnership with a top-20 pharmaceutical company for regulatory consulting30% success
• Q4 2026Expansion into European regulatory consulting services25% success
• Q3 2026Key hire of a former FDA senior reviewer as Chief Regulatory Officer40% success